News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
37,741 Results
Type
Article (1804)
Company Profile (17)
Press Release (35919)
Multimedia
Podcasts (40)
Webinars (11)
Section
Business (9051)
Career Advice (110)
Deals (1545)
Drug Delivery (18)
Drug Development (2444)
Employer Resources (27)
FDA (710)
Job Trends (1021)
News (13710)
Policy (1237)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 Genetown Elite (1)
Academia (173)
Accelerated approval (1)
ADA (4)
Adcomms (2)
Allergies (8)
Alliances (2498)
ALS (7)
Alzheimer's disease (70)
Antibody-drug conjugate (ADC) (33)
Approvals (728)
Artificial intelligence (139)
ASCO (27)
Autoimmune disease (22)
Automation (14)
Bankruptcy (12)
Best Places to Work (938)
BIO (3)
BIOSECURE Act (1)
Biosimilars (15)
Biotechnology (10)
Bladder cancer (9)
Brain cancer (3)
Breast cancer (55)
Cancer (405)
Cardiovascular disease (31)
Career advice (106)
Career pathing (6)
CAR-T (20)
CDC (1)
Cell therapy (63)
Cervical cancer (4)
Clinical research (2115)
Collaboration (203)
Compensation (33)
Complete response letters (1)
COVID-19 (248)
CRISPR (27)
C-suite (105)
Cystic fibrosis (10)
Data (538)
Denatured (19)
Depression (9)
Dermatology (11)
Diabetes (32)
Diagnostics (517)
Digital health (7)
Diversity (3)
Diversity, equity & inclusion (9)
Drug discovery (47)
Drug pricing (15)
Drug shortages (3)
Duchenne muscular dystrophy (10)
Earnings (3450)
Editorial (5)
Employer branding (3)
Employer resources (25)
Events (4123)
Executive appointments (117)
FDA (993)
Fibrodysplasia Ossificans Progressiva (1)
Funding (119)
Gene editing (39)
Generative AI (20)
Gene therapy (55)
GLP-1 (55)
Government (358)
Guidances (72)
Healthcare (1143)
Hematology (19)
HIV (25)
IgA nephropathy (8)
Immunology and inflammation (7)
Immuno-oncology (11)
Indications (14)
Infectious disease (276)
Inflammatory bowel disease (9)
Inflation Reduction Act (5)
Influenza (21)
Intellectual property (17)
Interviews (13)
IPO (692)
IRA (4)
Job creations (120)
Job search strategy (81)
JPM (13)
Kidney cancer (4)
Labor market (16)
Layoffs (38)
Leadership (9)
Legal (139)
Liver cancer (3)
Longevity (1)
Lung cancer (46)
Lymphoma (29)
Machine learning (10)
Management (9)
Manufacturing (145)
MASH (5)
Medical device (755)
Medtech (771)
Mergers & acquisitions (964)
Metabolic disorders (82)
mRNA (17)
Multiple sclerosis (11)
Neurodegenerative disease (14)
Neuropsychiatric disorders (3)
Neuroscience (147)
NextGen: Class of 2026 (346)
Non-profit (254)
Now hiring (2)
Obesity (39)
Opinion (57)
Ovarian cancer (8)
Pain (7)
Pancreatic cancer (6)
Parkinson's disease (9)
Partnered (11)
Patents (27)
Patient recruitment (29)
Peanut (3)
People (3342)
Pharmaceutical (4)
Pharmacy benefit managers (2)
Phase 1 (589)
Phase 2 (766)
Phase 3 (937)
Pipeline (865)
Policy (34)
Postmarket research (86)
Preclinical (248)
Press Release (6)
Prostate cancer (37)
Psychedelics (1)
Radiopharmaceuticals (30)
Rare diseases (66)
Real estate (261)
Recruiting (11)
Regulatory (1081)
Reports (13)
Research institute (181)
Resumes & cover letters (16)
Rett syndrome (1)
RNA editing (4)
RSV (3)
Schizophrenia (18)
Series A (20)
Series B (14)
Service/supplier (1)
Sickle cell disease (4)
Spinal muscular atrophy (4)
Sponsored (11)
Startups (187)
State (1)
Stomach cancer (1)
Supply chain (7)
Tariffs (4)
The Weekly (20)
Vaccines (74)
Venture capital (9)
Weight loss (22)
Women's health (19)
Worklife (3)
Date
Last 7 days (32)
Last 30 days (140)
Last 365 days (2164)
2026 (1307)
2025 (1934)
2024 (2138)
2023 (2129)
2022 (4530)
2021 (5442)
2020 (5369)
2019 (2699)
2018 (1836)
2017 (1343)
2016 (1249)
2015 (1278)
2014 (923)
2013 (792)
2012 (812)
2011 (825)
2010 (578)
Location
Africa (47)
Alabama (20)
Alaska (1)
Arizona (25)
Asia (1495)
Australia (197)
California (891)
Canada (272)
China (96)
Colorado (38)
Connecticut (97)
Delaware (17)
Europe (4308)
Florida (106)
Georgia (37)
Hawaii (1)
Idaho (3)
Illinois (122)
India (9)
Indiana (34)
Iowa (11)
Japan (48)
Kansas (6)
Kentucky (1)
Louisiana (6)
Maine (20)
Maryland (65)
Massachusetts (643)
Michigan (20)
Minnesota (30)
Missouri (5)
Montana (2)
Nebraska (2)
Nevada (12)
New Hampshire (2)
New Jersey (188)
New Mexico (4)
New York (212)
North Carolina (99)
North Dakota (3)
Northern California (458)
Ohio (37)
Oklahoma (1)
Oregon (1)
Pennsylvania (257)
Puerto Rico (2)
Rhode Island (6)
South America (51)
South Carolina (4)
South Dakota (1)
Southern California (354)
Tennessee (17)
Texas (113)
United States (3150)
Utah (24)
Virginia (18)
Washington D.C. (4)
Washington State (74)
Wisconsin (9)
37,741 Results for "evolve biosystems".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
EvolveImmune Therapeutics Highlights Progress for Lead Asset EVOLVE104 and EVOLVE T Cell Engager Platform in Multiple Presentations at 2026 AACR Annual Meeting
April 22, 2026
·
5 min read
Press Releases
EvolveImmune Therapeutics to Present Update on Lead Asset EVOLVE104 and New Data for EVOLVE T Cell Engager Platform at 2026 AACR Annual Meeting
April 14, 2026
·
3 min read
Press Releases
Battelle Launches The BLOOM Conference, Evolving Its Bioremediation Event
May 29, 2026
·
2 min read
Podcast
Sentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water
The vibe at BIO 2026 in San Diego last week was overwhelmingly positive, with attendees observing noticeable changes at the FDA and an uptick in dealmaking and IPOs. Plus, a top medical journal this week retracted a pivotal study for Amgen’s rare disease drug Tavneos, which has been in the FDA’s crosshairs since January.
July 1, 2026
·
2 min read
·
Jef Akst
Press Releases
Vicore Pharma to Host Webcast to Discuss Buloxibutid and the Evolving IPF Treatment Landscape
June 2, 2026
·
1 min read
Press Releases
OSE Immunotherapeutics Evolves its Leadership Team
April 15, 2026
·
5 min read
Press Releases
Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape
June 30, 2026
·
10 min read
Editorial
BioSpace
elevates journalism as biopharma evolves in the Trump era
Neal and Azbee awards have validated our approach to reporting on the industry at a time of unprecedented shifts at the FDA and other federal agencies.
April 24, 2026
·
4 min read
·
Jef Akst
Press Releases
Leica Biosystems Announces Expansion of Collaboration to Scale Precision Medicine and Develop AI-Powered Diagnostics
June 3, 2026
·
4 min read
Press Releases
Nona Biosciences Evolves Brand to Reflect Next Phase of Growth in Biotherapeutic Innovation
May 6, 2026
·
3 min read
1 of 3,775
Next
